
Joe Marttila, Revitas
Advertisement
Articles by Joe Marttila, Revitas

Advertisement
Latest Updated Articles
Maintain your integrity: manufacturers and the 340B integrity provisionPublished: July 12th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Trade & Channel Strategies 2025: Channel Strategies Evolve, With Industry Leaders Pushing Toward Faster, More Connected Patient Access
2
Trade & Channel Strategies 2025: How Regulatory & Patent Cliff Disruption is Remaking Pharma Channels
3
Pharma Pulse: FDA Shifts CAR-T Standards and Maryland Expands Medical Class Size, as Pharma Channels Brace for Massive Patent Cliff Disruption
4
How AI-Powered Precision Is Reshaping Medical Affairs
5
